ListedMainboardGLS
Glenmark Life Sciences Limited
Glenmark Life Sciences Limited is a mainboard IPO raising ₹1,513 Cr at ₹695 – ₹720 a share. It listed on 6 Aug 2021 and trades at ₹1,107 today, +53.7% against its issue price of ₹720. It was subscribed 44× in total.
₹720
Issue price
₹1,107
Price now
+53.7%
Since issue price
6 Aug 2021
Listed on
44×Subscribed (final) · all exchanges
44.2 times more demand than shares on offer
populated partly populated we hold nothing here — the tab says why
Lead managers, and how their past issues have done
Median return since issue price across every IPO we hold this bank on. Not a forecast for this issue — a record.
| Lead manager | IPOs we hold them on | Of which we can price | Median return since issue |
|---|---|---|---|
| DAM Capital Advisors Limited | 35 | 34 | +13.5% |
| BOB Capital Markets Limited | 9 | 8 | +33.2% |
| SBI Capital Markets Limited | 63 | 53 | +6.4% |
A bank appears on an issue we can price only when the company is matched to our price history, so the two counts differ. See the full league table →
Registrar
Contact them about allotment, refunds or unblocking your application amount — not the company, and not the exchange.
NameKARVY
ContactRudalf Corriea
Emailcomplianceofficer@glenmarklifesciences.com
Phone+91 2189 234456/ +91 2189 234246